Brief: Touyun Biotech Group Posts H1 Revenue HKD74.3 Mln
23/08/2024 12:18
Aug 23 (Reuters) - Touyun Biotech Group H1 gross margin 43.7%. * H1 revenue HKD 74.3 million * H1 net income HKD -48 million
Recent news on Touyun Biotech
See all newsHong Kong's Touyun Biotech profit surges on fair value gains
Brief: Touyun Biotech Group Sees Hk$180 Million-Hk$200 Million Profit And Total Comprehensive Income Attributable For HY2026
Brief: Touyun Biotech To Issue 123 Million New Shares At Hk$0.122 Per Share
Brief: Touyun Biotech Appoints Zhou Ruijuan As Executive Director And Vice Chairlady
Brief: Touyun Biotech Group Posts FY Revenue HKD 67 Million